Advanced search
Publication Cover
Substance Abuse Volume 37, 2016 - Issue 2
Journal homepage
787
Views
3
CrossRef citations to date
0
Altmetric
Editorials

Integrating policy and research into addiction practice, AMERSA abstracts, and an appreciation to our reviewers

Adam J. GordonSection of Treatment, Research, and Education in Addiction Medicine, Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA;Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USACorrespondence[email protected]
, MD, MPH
Pages 271-275 | Published online: 11 May 2016

References

  • Longest BB. Health Policymaking in the United States. 2nd ed. Chicago, IL: Health Administration Press; 1998.
  • Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624–1632.
  • McLellan AT, Woodworth AM. The affordable care act and treatment for “substance use disorders”: Implications of ending segregated behavioral healthcare. J Subst Abuse Treat. 2014;46:541–545.
  • Capoccia VA, Grazier KL, Toal C, Ford JH 2nd, Gustafson DH. Massachusetts's experience suggests coverage alone is insufficient to increase addiction disorders treatment. Health Aff (Millwood). 2012;31:1000–1008.
  • Woody GE. Progress in addiction treatment: From one-size-fits-all to medications and treatment matching. Subst Abus. 2014;35:110–113.
  • Roll JM, Kennedy J, Tran M, Howell D. Disparities in unmet need for mental health services in the United States, 1997–2010. Psychiatr Serv. 2013;64:80–82.
  • Stein BD, Gordon AJ, Dick AW, et al. Supply of buprenorphine waivered physicians: The influence of state policies. J Subst Abuse Treat. 2015;48:104–111.
  • Burns RM, Pacula RL, Bauhoff S, et al. Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013. Subst Abus. 2016;37:63–69.
  • Clark RE, Baxter JD, Barton BA, Aweh G, O'Connell E, Fisher WH. The impact of prior authorization on buprenorphine dose, relapse rates, and cost for Massachusetts Medicaid beneficiaries with opioid dependence. Health Serv. Res. 2014;49:1964–1979.
  • Baxter JD, Clark RE, Samnaliev M, Aweh G, O'Connell E. Adherence to buprenorphine treatment guidelines in a Medicaid program. Subst Abus. 2015;36:174–182.
  • Gordon AJ. Substance Abuse journal: New beginnings. Subst Abus. 2013;34:339–341.
  • Hopfer C. Implications of marijuana legalization for adolescent substance use. Subst Abus. 2014;35:331–335.
  • Black JJ, Chung T. Mechanisms of change in adolescent substance use treatment: How does treatment work? Subst Abus. 2014;35:344–351.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.